Gut Health 50 Billion
Natural health product licensed in Canada
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80132709
- Status
- Active licence
- Licence date
- 23 July 2024
- Revision date
- 20 October 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Bifidobacterium bifidum Source : BBR8 | 1.5 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 1.5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis Source : HN019 | 1.8 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : LA-01 | 5 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 5 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei Source : LPC-37 | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bi-26 | 0.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. infantis Source : Bifidobacterium longum subsp. Infantis - Whole Cell | 0.5 Milliards d'UFC | Not calculated |
| Lactobacillus delbrueckii subsp. bulgaricus Source : LB-87 | 0.05 Milliards d'UFC | Not calculated |
| Lacticaseibacillus Casei Source : LC-11 | 0.5 Milliards d'UFC | Not calculated |
| Lacticaseibacillus rhamnosus Source : GG | 6 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : BL-05 | 1 Milliards d'UFC | Not calculated |
| Lactobacillus gasseri Source : LG-36 | 2.5 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : KABP-023 | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Lactobacillus helveticus Source : SP27 | 1 Milliards d'UFC | Not calculated |
| Lactobacillus helveticus Source : Lactobacillus helveticus - Whole Cell | 1 Milliards d'UFC | Not calculated |
| Limosilactobacillus Reuteri Source : 1E1 | 2.5 Milliards d'UFC | Not calculated |
| Bifidobacterium animalis subsp. lactis | 6 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : Bifidobacterium breve - Cellule entière | 5 Milliards d'UFC | Not calculated |
| Bifidobacterium breve Source : BBR8 | 5 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : Pediococcus acidilactici - Whole Cell | 1 Milliards d'UFC | Not calculated |
| Pediococcus acidilactici Source : KABP-021 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
D-Mannitol, Sucrose, Dextrose, Cellulose microcristalline, Trehalose, Hypromellose, Carbonate de magnésium, Phosphate de potassium, dibasique, Phosphate de potassium, monobasique, Ascorbate de sodium, Citrate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Helps to manage acute infectious diarrhoea. Source of Probiotics. Helps to improve gut-related stress/discomfort in 6 weeks. Helps improve quality of life in patients with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence. Helps relief symptoms of irritable bowel syndrome (IBS). Helps improve IBS-related quality of life in patients with IBS and diarrhea. Helps relieve the symptoms of irritable bowel syndrome (IBS) (abdominal pain, bloating, distension). Helps to manage patients' IBS symptoms that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort. Helps to improve IBS gut-related stress/discomfort in 6 weeks. Promotes favourable gut flora/intestinal microflora. Reduces whole gut transit time/helps to accelerate intestinal transit time. Supports digestion by reducing transit time. Reduces frequency of functional gastrointestinal symptoms (e.g. constipation, irregularity, flatulence). Promotes bowel movement. Helps provide gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80132709
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.